# SACCHARIN SODIUM

URL: https://app.greenveil.ai/ingredients/ingredient_unii_sb8_zux40_ty
Categories: pharma
Identifier: chembl:CHEMBL2219743

> SACCHARIN SODIUM. Route: BUCCAL; Dosage form: FILM; Maximum daily exposure: 3 mg Assessed from 37 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: Route: BUCCAL; Dosage form: FILM; Maximum daily exposure: 3 mg

## Regulatory status

- US: inactive ingredient database — Route: BUCCAL; Dosage form: FILM; Maximum daily exposure: 3 mg
- US: inactive ingredient database — Route: BUCCAL; Dosage form: FILM, SOLUBLE; Maximum daily exposure: 2 mg
- US: inactive ingredient database — Route: BUCCAL; Dosage form: TABLET; Potency: 0.4 mg
- US: inactive ingredient database — Route: DENTAL; Dosage form: GEL; Potency: 0.3 %w/w
- US: inactive ingredient database — Route: DENTAL; Dosage form: OINTMENT; Potency: NA
- US: inactive ingredient database — Route: DENTAL; Dosage form: PASTE; Potency: 0.3 %w/w
- US: inactive ingredient database — Route: DENTAL; Dosage form: PASTE, DENTIFRICE; Potency: 0.2 %w/w
- US: inactive ingredient database — Route: DENTAL; Dosage form: SOLUTION; Potency: 0.05 %w/v
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION; Maximum daily exposure: 22 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 22 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 24 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CONCENTRATE; Maximum daily exposure: 6 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: ELIXIR; Potency: 15 mg/5ml
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE, FOR SOLUTION; Potency: 5.5 mg/120ml
- US: inactive ingredient database — Route: ORAL; Dosage form: LIQUID; Maximum daily exposure: 3 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: PASTE; Maximum daily exposure: 3 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SOLUTION; Maximum daily exposure: 5 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 85 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 665 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Potency: 5000 mg/5ml
- US: inactive ingredient database — Route: ORAL; Dosage form: SYRUP; Maximum daily exposure: 24 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 43 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 84 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED; Potency: 2 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FOR SUSPENSION; Maximum daily exposure: 6 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 10 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: WAFER; Potency: 8 mg
- US: inactive ingredient database — Route: RECTAL; Dosage form: SOLUTION; Maximum daily exposure: 665 mg
- US: inactive ingredient database — Route: RECTAL; Dosage form: SUSPENSION; Maximum daily exposure: 290 mg
- US: inactive ingredient database — Route: RECTAL; Dosage form: TABLET; Potency: 0.6 mg
- US: inactive ingredient database — Route: RESPIRATORY (INHALATION); Dosage form: AEROSOL, METERED; Potency: 0.05 %w/w
- US: inactive ingredient database — Route: RESPIRATORY (INHALATION); Dosage form: SOLUTION; Potency: NA
- US: inactive ingredient database — Route: SUBLINGUAL; Dosage form: TABLET; Maximum daily exposure: 7 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: OINTMENT; Potency: NA
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as chemical.

_Assessed by Greenveil._